🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study was to evaluate the feasibility of TS determination in...
Status
Completed
Location
Department of General, Visceral, and Transplantations Surgery, Univeristy of Ulm
Start Date
2001-07
Trial ID
NCT01212718
Treatments Being Tested
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
Chemotherapy given together is a standard way to treat your cancer. One sta...
Status
Completed
Location
City of Hope Cancer Center
Start Date
2006-10-23
Trial ID
NCT00515411
This study will aims to determine the maximum tolerated dose of CGC-11047 w...
Status
Completed
Location
Rocky Mountain Cancer Centre
Start Date
2006-05
Trial ID
NCT00705874
This multicentric randomized trial will compare the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06210360
Treatments Being Tested
This study will determine which of the two following treatment regimens pro...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2003-01
Trial ID
NCT00052962
Treatments Being Tested
This is an open-label, multicenter, Phase Ib trial designed to evaluate the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07649655
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy of deep regiona...
Status
Recruiting
Location
University Hospital
Start Date
2024-09-11
Trial ID
NCT06831981
The aim of the current work is to evaluate the efficacy and safety of intra...
Status
Unknown
Location
Multiple Locations
Start Date
2023-02-22
Trial ID
NCT05599971
Protocol PEN-866-001 is an open-label, multi-center, first-in-human Phase 1...
Status
Unknown
Location
Highlands Oncology Group
Start Date
2017-08-29
Trial ID
NCT03221400
Treatments Being Tested